To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.

H.R. 7352, introduced in the 119th Congress on February 4, 2026, aims to amend the Public Health Service Act by creating a program focused on developing innovative antimicrobial drugs targeting difficult pathogens and severe infections.